UNC- Chapel Hill

Running trials

• Not yet recruiting

  Treating Binge Eating and Obesity Digitally in Women

  NCT05693896· Source

• Active, not recruiting

  Preventing Type 2 Diabetes in Black Emergent Adult

  NCT06848244· Source

• Recruiting

  BOOM-IBD2 Pivotal Clinical Trial

  NCT06571669· Source

• Recruiting

  QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

  NCT06551116· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· Phase 2· Source

• Recruiting

  RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  NCT06121297· Phase 1/2· Source

• Recruiting

  Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05571059· Phase 2· Source

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Source

• Recruiting

  Lupus Landmark Study: A Prospective Registry and Biorepository

  NCT05934149· Source

• Active, not recruiting

  A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

  NCT05926765· Phase 2· Source

• Active, not recruiting

  Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  NCT05099770· Phase 3· Source

• Recruiting

  ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  NCT05059444· Source

• Active, not recruiting

  QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

  NCT03022825· Phase 2/3· Source

• Recruiting

  Pulmonary Hypertension Association Registry

  NCT04071327· Source

• Enrolling by invitation

  University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository

  NCT02427269· Source

• Recruiting

  Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  NCT01915511· Source

• Active, not recruiting

  Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

  NCT01844986· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and esophageal cancer2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Lupus (SLE)2 recruiting
• Bladder cancer1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis

  NCT05962788· Phase 3· Source

• Completed

  A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  NCT06254612· Phase 2· Source

• Completed

  COVID19 OutcomeS in Myeloma and the Impact of VaCcines

  NCT05831787· Source

• Completed

  Adaptation of a Values Assessment Tool

  NCT07068477· Source

• Completed

  How to Get Started: Identifying the Critical Ingredients to Improve Gait Initiation in Parkinson Disease

  NCT05625789· Source

• Completed

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· Phase 3· Source

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Source